Literature DB >> 11176570

Immunologic correlates of protection induced by vaccination.

S A Plotkin1.   

Abstract

Vaccine design and licensing depend on the choice of protective antigens and the demonstration of their efficacy. Ideally efficacy correlates with some measurement of immune response, although occasionally the correlation is weak and in the case of some vaccines uncertain. This paper attempts to review what is known about correlates of vaccine-induced protection. Although mucosal and cellular immune responses are clearly important to protection by some vaccines, most vaccines licensed today depend for their efficacy on serum antibodies. Particular levels of antibodies can be identified that confer protection most of the time. A condition for the efficacy of antibodies is functionality, i.e. their ability to kill or inactivate pathogens. The immune system is redundant, and the different types of responses to vaccines act synergistically.

Mesh:

Substances:

Year:  2001        PMID: 11176570     DOI: 10.1097/00006454-200101000-00013

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  69 in total

1.  Nomenclature for immune correlates of protection after vaccination.

Authors:  Stanley A Plotkin; Peter B Gilbert
Journal:  Clin Infect Dis       Date:  2012-03-20       Impact factor: 9.079

Review 2.  Correlates of protection induced by vaccination.

Authors:  Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

Review 3.  Immunization of preterm infants.

Authors:  Arnaud Gagneur; Didier Pinquier; Caroline Quach
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 4.  A history of hookworm vaccine development.

Authors:  Brent Schneider; Amar R Jariwala; Maria Victoria Periago; Maria Flávia Gazzinelli; Swaroop N Bose; Peter J Hotez; David J Diemert; Jeffrey M Bethony
Journal:  Hum Vaccin       Date:  2011-11-01

5.  Factors associated with protective antibody levels to vaccine preventable diseases in internationally adopted children.

Authors:  Laura Patricia Stadler; Stephanie Donauer; Marilyn Rice; Indi Trehan; Shelia Salisbury; Mary Allen Staat
Journal:  Vaccine       Date:  2010-10-29       Impact factor: 3.641

Review 6.  Immune dysregulation and chronic stress among older adults: a review.

Authors:  Jean-Philippe Gouin; Liisa Hantsoo; Janice K Kiecolt-Glaser
Journal:  Neuroimmunomodulation       Date:  2008-11-26       Impact factor: 2.492

7.  Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine.

Authors:  Natasha B Halasa; Alice O'Shea; Jian R Shi; Bonnie J LaFleur; Kathryn M Edwards
Journal:  J Pediatr       Date:  2008-04-28       Impact factor: 4.406

8.  Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantation.

Authors:  Hiroto Inaba; Christine M Hartford; Deqing Pei; Meredith J Posner; Jie Yang; Randall T Hayden; Ashok Srinivasan; Brandon M Triplett; Jon A McCulllers; Ching-Hon Pui; Wing Leung
Journal:  Br J Haematol       Date:  2011-10-24       Impact factor: 6.998

9.  Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigen.

Authors:  Joseph M Thompson; Alan C Whitmore; Herman F Staats; Robert E Johnston
Journal:  Vaccine       Date:  2008-06-09       Impact factor: 3.641

10.  Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model.

Authors:  Laurent Coudeville; Fabrice Bailleux; Benjamin Riche; Françoise Megas; Philippe Andre; René Ecochard
Journal:  BMC Med Res Methodol       Date:  2010-03-08       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.